Calarota SA - Search Results

1

Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.

Biancheri P, Di Sabatino A, Rovedatti L, Giuffrida P, Calarota SA, Vetrano S, Vidali F, Pasini A, Danese S, Corazza GR, MacDonald TT. Biancheri P, et al. Among authors: calarota sa. Inflamm Bowel Dis. 2013 Feb;19(2):259-64. doi: 10.1097/MIB.0b013e31828100a4. Inflamm Bowel Dis. 2013. PMID: 23328772

2

Role of IL-15 in immune-mediated and infectious diseases.

Di Sabatino A, Calarota SA, Vidali F, Macdonald TT, Corazza GR. Di Sabatino A, et al. Among authors: calarota sa. Cytokine Growth Factor Rev. 2011 Feb;22(1):19-33. doi: 10.1016/j.cytogfr.2010.09.003. Epub 2010 Nov 11. Cytokine Growth Factor Rev. 2011. PMID: 21074481 Review.

3

Nanochemistry-based immunotherapy for HIV-1.

Lori F, Calarota SA, Lisziewicz J. Lori F, et al. Among authors: calarota sa. Curr Med Chem. 2007;14(18):1911-9. doi: 10.2174/092986707781368513. Curr Med Chem. 2007. PMID: 17691933 Review.

4

IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine.

Calarota SA, Dai A, Trocio JN, Weiner DB, Lori F, Lisziewicz J. Calarota SA, et al. Vaccine. 2008 Sep 19;26(40):5188-95. doi: 10.1016/j.vaccine.2008.03.067. Epub 2008 Apr 14. Vaccine. 2008. PMID: 18462844 Free PMC article.

5

Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory molecule.

Calarota SA, Hokey DA, Dai A, Jure-Kunkel MN, Balimane P, Weiner DB. Calarota SA, et al. Vaccine. 2008 Jun 13;26(25):3121-34. doi: 10.1016/j.vaccine.2008.02.017. Epub 2008 Feb 22. Vaccine. 2008. PMID: 18336959

6

Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications.

Calarota SA, Aberle JH, Puchhammer-Stöckl E, Baldanti F. Calarota SA, et al. J Clin Virol. 2015 Sep;70:109-119. doi: 10.1016/j.jcv.2015.07.299. Epub 2015 Jul 26. J Clin Virol. 2015. PMID: 26305832 Review.

7

HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals.

Calarota SA, Foli A, Maserati R, Baldanti F, Paolucci S, Young MA, Tsoukas CM, Lisziewicz J, Lori F. Calarota SA, et al. J Immunol. 2008 May 1;180(9):5907-15. doi: 10.4049/jimmunol.180.9.5907. J Immunol. 2008. PMID: 18424710

8

Cytokine-adjuvanted HIV-DNA vaccination strategies.

Lori F, Weiner DB, Calarota SA, Kelly LM, Lisziewicz J. Lori F, et al. Among authors: calarota sa. Springer Semin Immunopathol. 2006 Nov;28(3):231-8. doi: 10.1007/s00281-006-0047-y. Epub 2006 Oct 20. Springer Semin Immunopathol. 2006. PMID: 17053912 Review.

9

Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.

Calarota SA, Weiner DB, Lori F, Lisziewicz J. Calarota SA, et al. Vaccine. 2007 Apr 20;25(16):3070-4. doi: 10.1016/j.vaccine.2007.01.024. Epub 2007 Jan 22. Vaccine. 2007. PMID: 17292518

10

The potential of topical DNA vaccines adjuvanted by cytokines.

Lisziewicz J, Calarota SA, Lori F. Lisziewicz J, et al. Among authors: calarota sa. Expert Opin Biol Ther. 2007 Oct;7(10):1563-74. doi: 10.1517/14712598.7.10.1563. Expert Opin Biol Ther. 2007. PMID: 17916048 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters